Hochschulschrift
Molecular characterization and phenotyping of circulating tumor cells for therapy optimization in metastatic breast cancer
- Weitere Titel
-
Molekulare Charakterisierung und Phänotypisierung zirkulierender Tumorzellen zur Therapieoptimierung beim metastasierten Mammakarzinom
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Düsseldorf, Heinrich-Heine-Universität, Dissertation, 2016
- Schlagwort
-
Krebs
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Düsseldorf
- (wer)
-
Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf
- (wann)
-
2016
- Urheber
-
Schneck, Helen
- Beteiligte Personen und Organisationen
-
Neubauer, Hans
- URN
-
urn:nbn:de:hbz:061-20161107-114458-3
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:52 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
- Schneck, Helen
- Neubauer, Hans
- Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf
Entstanden
- 2016
Ähnliche Objekte (12)
EMT-specific circulating micro RNAs and circulating tumor cells in metastatic breast cancer
Investigation of circulating microRNAs and circulating DNA as diagnostic and prognostic markers in metastatic breast cancer
53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients
Phenotyping of circulating monocytes in coronary artery diseases
Enrichment, isolation and molecular characterization of circulating tumour cells for treatment optimization in metastatic breast cancer
Therapeutic management of metastatic breast cancer
Investigation of circulating free DNA as independent indicator of impending recurrence in former breast cancer and prognostic marker in metastatic breast cancer
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry
Therapy landscape in patients with metastatic her2-positive breast cancer: Data from the praegnant real-world breast cancer registry
Prognostic impact of circulating tumor cells assessed with the CellSearch System and AdnaTest Breast in metastatic breast cancer patients: the DETECT study
The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients
Breast diseases : breast-conserving therapy, non-invasive therapy, mastopathy
EMT-specific circulating micro RNAs and circulating tumor cells in metastatic breast cancer
Investigation of circulating microRNAs and circulating DNA as diagnostic and prognostic markers in metastatic breast cancer
53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients
Phenotyping of circulating monocytes in coronary artery diseases
Enrichment, isolation and molecular characterization of circulating tumour cells for treatment optimization in metastatic breast cancer
Therapeutic management of metastatic breast cancer
Investigation of circulating free DNA as independent indicator of impending recurrence in former breast cancer and prognostic marker in metastatic breast cancer
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry
Therapy landscape in patients with metastatic her2-positive breast cancer: Data from the praegnant real-world breast cancer registry
Prognostic impact of circulating tumor cells assessed with the CellSearch System and AdnaTest Breast in metastatic breast cancer patients: the DETECT study
The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients
Breast diseases : breast-conserving therapy, non-invasive therapy, mastopathy
EMT-specific circulating micro RNAs and circulating tumor cells in metastatic breast cancer
Investigation of circulating microRNAs and circulating DNA as diagnostic and prognostic markers in metastatic breast cancer
53BP1 Accumulation in Circulating Tumor Cells Identifies Chemotherapy-Responsive Metastatic Breast Cancer Patients
Phenotyping of circulating monocytes in coronary artery diseases
Enrichment, isolation and molecular characterization of circulating tumour cells for treatment optimization in metastatic breast cancer
Therapeutic management of metastatic breast cancer
Investigation of circulating free DNA as independent indicator of impending recurrence in former breast cancer and prognostic marker in metastatic breast cancer
Therapy Landscape in Patients with Metastatic HER2-Positive Breast Cancer: Data from the PRAEGNANT Real-World Breast Cancer Registry
Therapy landscape in patients with metastatic her2-positive breast cancer: Data from the praegnant real-world breast cancer registry
Prognostic impact of circulating tumor cells assessed with the CellSearch System and AdnaTest Breast in metastatic breast cancer patients: the DETECT study
The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients